Abbott Laboratories (ABT:NYSE) Strategic SWOT, PESTLE and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI’s, and Recent Trends
- Report Code : QUA2755076
- Published On: Dec, 2023
- Category : Medical Devices
- Pages : 93
-
Report Summary
Abbott Laboratories (ABT:NYSE) Strategic SWOT, PESTLE and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI’s, and Recent Trends Report is a comprehensive and easily accessible overview of Abbott Laboratories's business operations. It provides a detailed analysis of the company's financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.
The report begins with in-depth information about Abbott Laboratories, including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.
Next, the report assesses Abbott Laboratories's strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. The PESTLE analysis evaluates the external factors impacting the company's operations and market environment. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of Abbott Laboratories's overall strategic standing and supports informed decision-making and strategic planning.
The report also covers Abbott Laboratories's financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares Abbott Laboratories's financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors' operations.
Finally, the report includes recent news and deal activities undertaken by Abbott Laboratories, enhancing awareness of the company's business trends, growth perspectives, and more.
Scope
• Tactical Analysis:- Various strategic frameworks to gain insights into a company's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
• Business Strategy:- Contributes to shaping the company's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
• Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company's future prospects. These components collectively contribute to understanding the financial health and market perception of the company.
• Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
• Competitive Landscape:- An identification of the company's main competitors, providing insights into the competitive landscape it operates in.
Reasons to Buy
• Comprehensive Understanding of the Abbott Laboratories's internal and external factors through SWOT analysis, PESTLE analysis, Financial Analysis, and Competitors Benchmarking.
• Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
• Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
• Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
• Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation.
• Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.
Additionally, available deep-dive analysis on the company Abbott Laboratories:
• Abbott Laboratories Porter's Five Forces Analysis
• Abbott Laboratories VRIO Analysis
• Abbott Laboratories BCG Analysis
• Abbott Laboratories Segmentation, Targeting and Positioning (STP) Analysis
• Abbott Laboratories Ansoff Matrix Analysis
-
With tables and figures helping analyze worldwide Abbott Laboratories (ABT NYSE) Strategic SWOT PESTLE and Financial Insights A 360 market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Tables
Charts
Abbott Laboratories - Key Company Facts
Abbott Laboratories - Company Description
Abbott Laboratories - Top Executives
Abbott Laboratories- Top Executives Biographies
Abbott Laboratories- Head Office & Locations
Head Office - Country
Key Subsidiaries
Abbott Laboratories - Products and Services
Products
Abbott Laboratories - Historic Events
Abbott Laboratories – Company’s Management Discussion
Abbott Laboratories – Company’s Mission and Vision
Mission
Abbott Laboratories - Corporate Strategy
Abbott Laboratories - Business Description
Established Pharmaceuticals
Medical Devices
Nutrition
Diagnostics
Abbott Laboratories - ESG Spotlight
Environment
Social
Corporate Governance
Abbott Laboratories - SWOT Analysis
Overview
Strengths
Weaknesses
Opportunities
Threats
Abbott Laboratories – PESTLE Analysis
Overview
Political Factors
Economic Factors
Social Factors
Technological Factors
Legal Factors
Environmental Factors
Abbott Laboratories - Financial Deep Dive
Share Price Trend - Dec-2022 to Nov-2023 (Average Share Closing Price)
Profit and Loss Statement
Summary of Profit and Loss Statement
Balance Sheet
Summary of Balance Sheet
Cash Flow Statement
Summary of Cash Flow Statement
Key Financial Ratio Analysis
Abbott Laboratories - Ratio Charts
Activity Ratio Charts
Growth Ratios Charts
Leverage Ratio Charts
Liquidity Ratio Charts
Profitability Ratio Charts
Competing Players
Snapshot of Competing Players
Boston Scientific Corporation
Key Company Facts
Company Description
Snapshot of Competing Players
Johnson & Johnson
Key Company Facts
Company Description
Snapshot of Competing Players
Sanofi
Key Company Facts
Company Description
Snapshot of Competing Players
Stryker Corporation
Key Company Facts
Company Description
Abbott Laboratories - Key Deals
23-Nov-2023 - Abbott to upgrade 75 primary health centres across india, providing quality, accessible care to 2.5 million people
24-Jun-2023 - The american diabetes association and abbott collaborate on first-of-its-kind therapeutic nutrition program for people with diabetes
31-May-2023 - Abbott, real madrid and the real madrid foundation band together to 'beat malnutrition' globally through new campaign
27-Apr-2023 - Abbott completes acquisition of cardiovascular systems, inc.
20-Apr-2023 - Abbott and new global consortium partnership address viral outbreaks caused by climate change
13-Dec-2022 - Abbott and the brain injury association of america launch concussion awareness now coalition; team up with rebel wilson to raise awareness on seriousness of concussions
12-Oct-2022 - Abbott and the home edit redesign the medicine cabinet to help people prepare for the upcoming virus season
04-Aug-2022 - Abbott and weightwatchers partner to support people living with diabetes in attaining their health goals
22-Jun-2022 - Easterseals and the abbott fund join together to advance education and health equity
27-Apr-2022 - Abbott, camdiab and ypsomed unveil new automated insulin delivery partnership for people with diabetes
Abbott Laboratories - In the News
05-Jul-2023 - Abbott receives fda approval for world's first dual chamber leadless pacemaker
03-Jul-2023 - Abbott receives fda clearance for first commercially available lab-based blood test to help evaluate concussion
22-Jun-2023 - Abbott's freestyle libre® 2 receives national reimbursement in france for all people with diabetes who use insulin¹
03-Jun-2023 - U.S. Fda clears abbott's freestyle libre® 2 and freestyle libre® 3 sensors for integration with automated insulin delivery systems
19-May-2023 - Abbott receives fda approval for tactiflex™ ablation catheter for treatment of abnormal heart rhythm
18-May-2023 - Abbott receives fda clearance for assert-iq™ insertable cardiac monitor to help doctors monitor people's heart rhythms long-term
16-May-2023 - Abbott receives fda approval for its spinal cord stimulation systems to treat chronic back pain in people who have limited surgical options
30-Mar-2023 - Abbott receives fda approval for epic™ max tissue valve to treat aortic valve disease
02-Feb-2023 - Abbott announces u.S. And european approvals for new technologies to support effective treatment for abnormal heart rhythms
19-Dec-2022 - Abbott launches the world's smallest implantable, rechargeable spinal cord stimulation system for chronic pain
Appendix
Definitions
SWOT Analysis
PESTLE Analysis
Value Chain Analysis
ESG Spotlight
Financial Deep Dive
Financial Ratios -
Activity Ratios
Growth Ratios
Leverage Ratios
Liquidity Ratios
Market Ratios
Profitability Ratios
Research Methodology
Disclaimer
Contact Us
-
The Abbott Laboratories (ABT NYSE) Strategic SWOT PESTLE and Financial Insights A 360 Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Abbott Laboratories (ABT NYSE) Strategic SWOT PESTLE and Financial Insights A 360 Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
In 2023, the Abbott Laboratories (ABT NYSE) Strategic SWOT PESTLE and Financial Insights A 360 Market share surpassed USD xx million, and between 2024 and 2029, it will grow at a CAGR of yy%.
Yes, the add-on segmentation is available in the premium customised version of the Abbott Laboratories (ABT NYSE) Strategic SWOT PESTLE and Financial Insights A 360 Market report for a more in-depth analysis. It aids in the calculation of refined and precise market values.
Companies in the Abbott Laboratories (ABT NYSE) Strategic SWOT PESTLE and Financial Insights A 360 Industry are thoroughly researched and profiled in order to determine why certain trends will have a significant impact and how they will be factored into the Abbott Laboratories (ABT NYSE) Strategic SWOT PESTLE and Financial Insights A 360 Market's trajectory and future outlook.